XML 59 R41.htm IDEA: XBRL DOCUMENT v3.25.2
Collaborative Arrangements and Licensing Agreements - Revenue from Collaborative Relationship from AstraZeneca (Details) - AstraZeneca [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Collaborative Arrangements and Licensing Agreements [Abstract]        
Revenue $ 54,288 $ 15,960 $ 74,577 $ 27,645
Strategic Partner [Member] | Revenue [Member]        
Collaborative Arrangements and Licensing Agreements [Abstract]        
Concentration percentage 12.00% 7.00% 13.00% 8.00%